Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study

Erythropoietic medications such as including erythropoietin (EPO) are known to be neuroprotective and to correlate with improved cognitive functions. However, it is not known whether supplementation with EPO reduces the risk of dementia in end-stage renal disease (ESRD) patients receiving hemodialys...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Peir-Haur, Yeh, Chih-Ching, Sung, Fung-Chang, Hsiao, Chih-Yen, Muo, Chih-Hsin, Hung, Kuan-Yu, Tsai, Kuen-Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756878/
https://www.ncbi.nlm.nih.gov/pubmed/31484803
http://dx.doi.org/10.18632/aging.102227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756878/
https://www.ncbi.nlm.nih.gov/pubmed/31484803
http://dx.doi.org/10.18632/aging.102227

Ejemplares similares